Lupin and Sun settle Bromsite patent suit after ruling
10-02-2022
Court denies Sun Pharma’s bid to avoid trial
25-11-2021
Pavel Kapysh / Shutterstock.com
A New Jersey court has invalidated a Sun Pharmaceuticals patent related to its anti-inflammatory eye drops BromSite in an infringement suit against generic drug manufacturer Lupin Pharmaceuticals.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Sun Pharmaceuticals, Lupin Pharmaceuticals, US District Court for the District of New Jersey, BromSite
